FDA Inspection 1136666 - Valescent Pharmaceuticals, Inc. dba VPI Compounding - March 03, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Valescent Pharmaceuticals, Inc. dba VPI Compounding, with an inspection on March 3, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Valescent Pharmaceuticals, Inc. dba VPI Compounding
Inspection Date: March 3, 2021
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 643638d5-54a5-4725-81f1-510a050cb7c8